Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 194.32 |
| Open | 195.06 |
| Bid | 193.45 x 900 |
| Ask | 203.91 x 800 |
| Day's range | 195.25 - 198.94 |
| 52-week range | 161.65 - 275.00 |
| Volume | |
| Avg. volume | 653,908 |
| Market cap | 10.254B |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | 23.76 |
| EPS (TTM) | 8.36 |
| Earnings date | 06 Nov 2024 - 11 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 224.59 |
ZacksCRL Stock May Benefit From New Neuroscience Research Collaboration
Charles River's new alliance with Insightec to advance therapeutic development using focused ultrasound in neuroscience.
ZacksWhy Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insider MonkeyHigher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The Mid Company Fund (Institutional shares) returned -7.85 % in the quarter significantly underperforming -3.21% return for the Russell Midcap Growth Index. The strategy focuses […]
© 2024 Yahoo. All rights reserved.